Treffer: Resistance Dynamics in a Romanian Critical Care Unit: Four Years of ESKAPE Pathogen Surveillance.

Title:
Resistance Dynamics in a Romanian Critical Care Unit: Four Years of ESKAPE Pathogen Surveillance.
Authors:
Sava M; County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.; Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania., Codru IR; County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.; Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania., Bereanu AS; County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.; Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania., Stoia O; County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.; Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania., Vintila BI; County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.; Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania.
Source:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2025 Nov 27; Vol. 61 (12). Date of Electronic Publication: 2025 Nov 27.
Publication Type:
Journal Article; Observational Study
Language:
English
Journal Info:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE
Imprint Name(s):
Publication: 2018- : Basel, Switzerland : MDPI
Original Publication: Kaunas : Lietuvos gydytojų sąjunga
References:
Infect Drug Resist. 2024 Nov 08;17:4913-4919. (PMID: 39534016)
J Clin Med. 2025 Feb 04;14(3):. (PMID: 39941669)
J Intensive Med. 2022 Nov 15;3(3):244-253. (PMID: 37533805)
Antibiotics (Basel). 2025 Aug 29;14(9):. (PMID: 41009850)
Infect Dis Clin North Am. 2021 Sep;35(3):827-839. (PMID: 34362546)
Surg Infect (Larchmt). 2014 Oct;15(5):474-8. (PMID: 24841214)
Ann Med Surg (Lond). 2023 May 12;85(6):2932-2939. (PMID: 37363470)
Microbiol Res. 2023 Jan;266:127249. (PMID: 36356348)
Nat Rev Microbiol. 2024 Oct;22(10):598-616. (PMID: 38831030)
Microorganisms. 2024 Mar 28;12(4):. (PMID: 38674628)
J Clin Med. 2025 Aug 18;14(16):. (PMID: 40869652)
Biomed Res Int. 2016;2016:2475067. (PMID: 27274985)
Risk Manag Healthc Policy. 2020 Sep 28;13:1765-1780. (PMID: 33061710)
Front Antibiot. 2023 Jun 30;2:1145190. (PMID: 39816646)
Lancet Infect Dis. 2017 Sep;17(9):990-1001. (PMID: 28629876)
NPJ Biofilms Microbiomes. 2025 May 19;11(1):79. (PMID: 40389466)
Curr Res Microb Sci. 2024 Dec 06;8:100331. (PMID: 39802320)
Clin Microbiol Rev. 2020 May 13;33(3):. (PMID: 32404435)
Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988)
Evid Based Nurs. 2023 Jul 27;:. (PMID: 37500506)
Antibiotics (Basel). 2025 Aug 12;14(8):. (PMID: 40868018)
Am J Infect Control. 2022 Dec;50(12):1281-1295. (PMID: 35525498)
Nat Commun. 2024 Jul 31;15(1):6447. (PMID: 39085269)
Microorganisms. 2024 Sep 21;12(9):. (PMID: 39338594)
BMC Infect Dis. 2023 Oct 13;23(1):686. (PMID: 37833675)
Medicina (Kaunas). 2023 May 31;59(6):. (PMID: 37374262)
Microorganisms. 2024 Sep 28;12(10):. (PMID: 39458275)
Antibiotics (Basel). 2024 Feb 01;13(2):. (PMID: 38391530)
Lancet Reg Health Eur. 2025 May 10;54:101318. (PMID: 40487777)
Int J Mol Sci. 2023 Mar 07;24(6):. (PMID: 36982221)
J Pers Med. 2024 Feb 14;14(2):. (PMID: 38392638)
Antibiotics (Basel). 2025 Jan 09;14(1):. (PMID: 39858349)
Pharmaceuticals (Basel). 2025 Jan 25;18(2):. (PMID: 40005975)
Int J Hyg Environ Health. 2022 Jul;244:114006. (PMID: 35841823)
J Biol Dyn. 2012;6:1088-104. (PMID: 23110346)
Infect Dis Ther. 2023 Jun;12(6):1527-1552. (PMID: 37273072)
Folia Microbiol (Praha). 2025 Jul 28;:. (PMID: 40717189)
Contributed Indexing:
Keywords: ESKAPE pathogens; antimicrobial resistance; intensive care unit; resistance trends
Substance Nomenclature:
0 (Anti-Bacterial Agents)
Entry Date(s):
Date Created: 20251231 Date Completed: 20251231 Latest Revision: 20260109
Update Code:
20260110
PubMed Central ID:
PMC12734538
DOI:
10.3390/medicina61122114
PMID:
41470116
Database:
MEDLINE

Weitere Informationen

Background and Objectives: Antimicrobial resistance is one of the most significant threats to modern healthcare, especially in intensive care units where ESKAPE pathogens -Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter spp.-account for the majority of healthcare-associated infections. Romania is among the European countries with the highest rates of antimicrobial consumption and resistance. This study aimed to describe the epidemiological trends and antimicrobial resistance profiles of ESKAPE isolates over a four-year period (2021-2024) in a Romanian ICU (Intensive Care Unit). Materials and Methods: We conducted a retrospective observational study of all microbiological samples collected from adult ICU patients at the Clinical Emergency County Hospital of Sibiu between 2021 and 2024. Data were extracted from the electronic laboratory system and included patient demographics, specimen types, isolated microorganisms, and antimicrobial resistance classifications. Statistical analyses were performed using Python libraries, with significance set at p < 0.05. Results: A total of 801 infections were recorded, of which 562 (70.2%) involved ESKAPE pathogens. The predominant organisms identified were Klebsiella pneumoniae (42.8%) and Acinetobacter baumannii (36.0%), followed by Pseudomonas aeruginosa (11.2%). Nearly half of the isolates (47.3%) were multidrug-resistant, and 22.3% were extensively drug-resistant. Respiratory specimens, particularly tracheal aspirates, accounted for the majority of the isolates and exhibited the highest proportion of resistant phenotypes. A significant temporal increase in extensively drug-resistant isolates was observed over the study period ( p < 0.05). Conclusions: ESKAPE pathogens remain the leading causes of ICU infections in Romania, with Klebsiella pneumoniae and Acinetobacter baumannii contributing significantly to the burden of multidrug- and extensively drug-resistant infections. Strengthening infection prevention strategies, optimizing antimicrobial stewardship, and implementing continuous microbiological surveillance are essential to mitigate the evolving resistance crisis in Romanian critical care settings.